Prognostic assays for rejection and tolerance in organ transplantation

Transplant Immunology

Volumn 14, Issue 3-4 SPEC. ISS., 2005, Pages 193-201

  Bradley, Benjamin A ^a  

^a East Barn   (United Kingdom)

Author keywords

Acute rejection; Immunosuppression; Monitoring; Organ transplantation; Regulation; Tolerance

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; B LYMPHOCYTE RECEPTOR; CALCINEURIN INHIBITOR; CASPASE 3; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; DEATH RECEPTOR; FAS LIGAND; GAMMA INTERFERON; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; CELL ACTIVITY; CELL DEATH; CELLULAR IMMUNITY; CLONAL ANERGY; CONFERENCE PAPER; CYTOTOXICITY; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNOLOGIC TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PROGNOSIS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 20744440038     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2005.03.022     Document Type: Conference Paper

References (71)

1. T.E. Starzl Chimerism and tolerance in transplantation Proc Natl Acad Sci U S A 101 Suppl. 2 2004 14607 14614
2. T. Okuda, T. Ishikawa, O. Azhipa, N. Ichikawa, A.J. Demetris, and T.E. Starzl Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells Transplantation 74 1 2002 103 111
3. J. Steinmann, J. Kaden, G. May, K. Schroder, C. Herwartz, and W. Muller-Ruchholtz Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation J Clin Lab Anal 8 3 1994 157 162
4. C. Susal, and G. Opelz Kidney graft failure and presensitization against HLA class I and class II antigens Transplantation 73 8 2002 1269 1273
5. G. Fernandez-Fresnedo, J.M. Pastor, M. Lopez-Hoyos, J.C. Ruiz, J.A. Zubimendi, and J. Gonzalez-Cotorruelo Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival Nephrol Dial Transplant 18 5 2003 990 995
6. R. McKenna, S. Takemoto, and P. Terasaki Anti-HLA antibodies after solid organ transplantation Transplantation 69 3 2000 319 326
7. A.L. Girnita, K.R. McCurry, A.T. Iacono, R. Duquesnoy, T.E. Corcoran, and M. Awad HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection J Heart Lung Transplant 23 10 2004 1135 11141
8. L.C. Paul Immunologic risk factors for chronic renal allograft dysfunction Transplantation 71 11 Suppl. 2001 SS17 SS23
9. E.R. Vasilescu, E.K. Ho, L. de la Torre, S. Itescu, C. Marboe, and R. Cortesini Anti-HLA antibodies in heart transplantation Transpl Immunol 12 2 2004 177 183
10. S. Le Bas-Bernardet, S. Coupel, A. Chauveau, J.P. Soulillou, and B. Charreau Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies Transplantation 78 12 2004 1729 1739
11. S. Le Bas-Bernardet, M. Hourmant, S. Coupel, J.D. Bignon, J.P. Soulillou, and B. Charreau Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis Am J Transplant 3 2 2003 167 177
12. Y.P. Jin, P.T. Jindra, K.W. Gong, E.J. Lepin, and E.F. Reed Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection Transplantation 79 3 2005 S19 S21
13. S. Sumitran-Holgersson, H.E. Wilczek, J. Holgersson, and K. Soderstrom Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts Transplantation 74 2 2002 268 277
14. A.J. Bathgate, V. Pravica, C. Perrey, G. Therapondos, J.N. Plevris, and P.C. Hayes The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection Transplantation 69 7 2000 1514 1517
15. D. Sankaran, A. Asderakis, S. Ashraf, I.S. Roberts, C.D. Short, and P.A. Dyer Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int 56 1 1999 281 288
16. M.C. Warle, H.J. Metselaar, W.C. Hop, and H.W. Tilanus Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis Liver Transpl 11 1 2005 19 26
17. H.X. Zheng, G.J. Burckart, K. McCurry, S. Webber, J. Ristich, and A. Iacono Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation J Heart Lung Transplant 23 5 2004 541 546
18. A.J. Bathgate, P. Lee, P.C. Hayes, and K.J. Simpson Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation Liver Transpl 6 6 2000 721 727
19. R. Weimer, S. Zipperle, V. Daniel, S. Carl, G. Staehler, and G. Opelz Superior 3-year kidney graft function in patients with impaired pretransplant Th2 responses Transpl Int 11 Suppl. 1 1998 S350 S356
20. M. Sadeghi, V. Daniel, R. Weimer, M. Wiesel, O. Hergesell, and G. Opelz Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients Clin Transplant 17 2 2003 151 157
21. C. Susal, S. Pelzl, T. Simon, and G. Opelz Advances in pre- and posttransplant immunologic testing in kidney transplantation Transplant Proc 36 1 2004 29 34
22. S. Pelzl, G. Opelz, M. Wiesel, P. Schnulle, C. Schonemann, and B. Dohler Soluble CD30 as a predictor of kidney graft outcome Transplantation 73 1 2002 3 6
23. K.W. Chan, C.D. Hopke, S.M. Krams, and O.M. Martinez CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses J Immunol 169 4 2002 1784 1791
24. C. Susal, S. Pelzl, and G. Opelz Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30 Transplantation 76 8 2003 1231 1232
25. C. Susal, S. Pelzl, and G. Opelz High pretransplant serum sCD30 content as a possible explanation for the high rejection rate in young kidney graft recipients Pediatr Transplant 7 48 2003 2003
26. B.A. Bradley Rejection and recipient age Transpl Immunol 10 2-3 2002 125 132
27. B.J. van der Mast, N.M. van Besouw, P. de Kuiper, L.M. Vaessen, P.J. Gregoor, and T. van Gelder Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression Transplantation 72 5 2001 873 880
28. Borel I. Malan, A. Racca, M.I. Garcia, A. Bailat, F. Quiroga, and A. Soutullo Gammadelta T cells and interleukin-6 levels could provide information regarding the progression of human renal allograft Scand J Immunol 58 1 2003 99 105
29. M. Sadeghi, V. Daniel, C. Naujokat, M. Wiesel, O. Hergesell, and G. Opelz Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection Transpl Int 18 2 2005 177 185
30. C.Y. Tong, A. Bakran, H. Williams, L.E. Cuevas, J.S. Peiris, and C.A. Hart Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation J Med Virol 64 1 2001 29 34
31. L.G. Hidalgo, and P.F. Halloran Role of IFN-gamma in allograft rejection Crit Rev Immunol 22 4 2002 317 349
32. N. Shulzhenko, A. Morgun, M. Franco, M.M. Souza, D.R. Almeida, and R.V. Diniz Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection Braz J Med Biol Res 34 6 2001 779 784
33. Y.L. Wang, Z.Q. Tang, W. Gao, Y. Jiang, X.H. Zhang, and L. Peng Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation Transplant Proc 35 8 2003 3024 3025
34. D.X. Zhao, Y. Hu, G.G. Miller, A.D. Luster, R.N. Mitchell, and P. Libby Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection J Immunol 169 3 2002 1556 1560
35. T. Simon, G. Opelz, M. Wiesel, S. Pelzl, R.C. Ott, and C. Susal Serial peripheral blood interleukin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection Transplantation 77 10 2004 1589 1595
36. A. Lun, M.Y. Cho, C. Muller, G. Staffa, W.O. Bechstein, and C. Radke Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation Clin Chim Acta 320 1-2 2002 69 78
37. A. Shoker, D. George, H. Yang, and M. Baltzan Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection Transplantation 70 3 2000 497 505
38. A.M. Posselt, F. Vincenti, M. Bedolli, M. Lantz, J.P. Roberts, and R. Hirose CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients Transplantation 76 1 2003 190 195
39. A.S. Shoker, Z.R. Lun, R. Choudry, and A. Saxena Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production Transpl Immunol 8 4 2001 219 228
40. G. Bohmig, and H. Regele Diagnosis and treatment of antibody-mediated kidney allograft rejection Transpl Int 16 11 2003 773 787
41. G. Rifle, C. Mousson, L. Martin, F. Guignier, and K. Hajji Donor-specific antibodies in allograft rejection: clinical and experimental data Transplantation 79 3 2005 S14 S18
42. Y.W. Sijpkens, S.A. Joosten, M.C. Wong, F.W. Dekker, H. Benediktsson, and I.M. Bajema Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy Kidney Int 65 6 2004 2409 2418
43. W.W. Hancock, L. Wang, Q. Ye, R. Han, and I. Lee Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression Curr Opin Immunol 15 5 2003 479 486
44. W.W. Hancock, B. Lu, W. Gao, V. Csizmadia, K. Faia, and J.A. King Requirement of the chemokine receptor CXCR3 for acute allograft rejection J Exp Med 192 10 2000 1515 1520
45. S. Segerer, Y. Cui, F. Eitner, T. Goodpaster, K.L. Hudkins, and M. Mack Expression of chemokines and chemokine receptors during human renal transplant rejection Am J Kidney Dis 37 3 2001 518 531
46. U. Panzer, R.R. Reinking, O.M. Steinmetz, G. Zahner, U. Sudbeck, and S. Fehr CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection Transplantation 78 9 2004 1341 1350
47. M. Melter, A. Exeni, M.E. Reinders, J.C. Fang, G. McMahon, and P. Ganz Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection Circulation 104 21 2001 2558 2564
48. N.M. Fahmy, M.H. Yamani, R.C. Starling, N.B. Ratliff, J.B. Young, and P.M. McCarthy Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants Transplantation 75 1 2003 72 78
49. J.A. Belperio, M.P. Keane, M.D. Burdick, J.P. Lynch III, D.A. Zisman, and Y.Y. Xue Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection J Immunol 171 9 2003 4844 4852
50. H. Hu, B.D. Aizenstein, A. Puchalski, J.A. Burmania, M.M. Hamawy, and S.J. Knechtle Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction Am J Transplant 4 3 2004 432 437
51. R.R. Tatapudi, T. Muthukumar, D. Dadhania, R. Ding, B. Li, and V.K. Sharma Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine Kidney Int 65 6 2004 2390 2397
52. B.H. Nelson IL-2, regulatory T cells, and tolerance J Immunol 172 7 2004 3983 3988
53. B.H. Nelson, and D.M. Willerford Biology of the interleukin-2 receptor Adv Immunol 70 1998 1 81
54. M.P. Hernandez-Fuentes, A.N. Warrens, and R.I. Lechler Immunologic monitoring Immunol Rev 196 2003 247 264
55. S. Le Rond, J. Le Maoult, C. Creput, C. Menier, M. Deschamps, and G. Le Friec Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients Eur J Immunol 34 3 2004 649 660
56. S.W. Chung, E.M. Yoshida, M.S. Cattral, Y. Hu, and R.M. Gorczynski Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production Immunol Lett 63 2 1998 91 96
57. G.V. Mazariegos, A.F. Zahorchak, J. Reyes, H. Chapman, A. Zeevi, and A.W. Thomson Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression Am J Transplant 5 2 2005 314 322
58. N.L. Reinsmoen Immunologic monitoring of T helper cell reactivity Transplant Proc 33 1-2 2001 302 303
59. W. Weimar, J. Rischen-Vos, P. de Kuiper, P.J. Gregoor, JN IJ, and N.M. van Besouw Tapering immunosuppression in recipients of living donor kidney transplants Nephrol Dial Transplant 19 Suppl. 4 2004 iv61 iv63
60. N.M. van Besouw, B.J. van der Mast, P. de Kuiper, P.J. Smak regoor, L.M. Vaessen, and J.N. Ijzermans Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantation Clin Exp Immunol 128 2 2002 388 393
61. P.I. Hornick, P.D. Mason, M.H. Yacoub, M.L. Rose, R. Batchelor, and R.I. Lechler Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans Circulation 97 13 1998 1257 1263
62. F.H. Claas Towards clinical transplantation tolerance Lancet 361 9368 2003 1489 1490
63. A. de Haan, I. van der Gun, B.G. Hepkema, W.J. de Boer, W. van der Bij, and L.F. de Leij Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome Transplantation 69 7 2000 1434 1439
64. L.L. Christensen, N. Grunnet, N. Rudiger, B. Moller, and S.A. Birkeland Indications of immunological tolerance in kidney transplantation Tissue Antigens 51 6 1998 637 644
65. S.R. Lederer, N. Friedrich, R. Gruber, R. Landgraf, M. Toepfer, and T. Sitter Reduced CD40L expression on ex vivo activated CD4+ T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure Int Arch Allergy Immunol 133 3 2004 276 284
66. A.D. Salama, N. Najafian, M.R. Clarkson, W.E. Harmon, and M.H. Sayegh Regulatory CD25+ T cells in human kidney transplant recipients J Am Soc Nephrol 14 6 2003 1643 1651
67. F. Meloni, P. Vitulo, A.M. Bianco, E. Paschetto, M. Morosini, and A. Cascina Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome Transplantation 77 5 2004 762 766
68. N. Suciu-Foca, J.S. Manavalan, and R. Cortesini Generation and function of antigen-specific suppressor and regulatory T cells Transpl Immunol 11 3-4 2003 235 244
69. R. Cortesini, E. Renna-Molajoni, P. Cinti, R. Pretagostini, E. Ho, and P. Rossi Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells Hum Immunol 63 11 2002 1010 1018
70. R. Ciubotariu, R. Vasilescu, E. Ho, P. Cinti, C. Cancedda, and L. Poli Detection of T suppressor cells in patients with organ allografts Hum Immunol 62 1 2001 15 20
71. J.R. Torrealba, M. Katayama, J.H. Fechner Jr., E. Jankowska-Gan, S. Kusaka, and Q. Xu Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+T regulatory cell infiltrates J Immunol 172 9 2004 5753 5764